These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 26886225)

  • 1. Mitochondrial involvement in myocyte death and heart failure.
    Goldenthal MJ
    Heart Fail Rev; 2016 Mar; 21(2):137-55. PubMed ID: 26886225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dynamics and cell death in heart failure.
    Marín-García J; Akhmedov AT
    Heart Fail Rev; 2016 Mar; 21(2):123-36. PubMed ID: 26872674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
    Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
    Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death.
    Papanicolaou KN; Ngoh GA; Dabkowski ER; O'Connell KA; Ribeiro RF; Stanley WC; Walsh K
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H167-79. PubMed ID: 22037195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and Cardiac Hypertrophy.
    Facundo HDTF; Brainard RE; Caldas FRL; Lucas AMB
    Adv Exp Med Biol; 2017; 982():203-226. PubMed ID: 28551789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrion as a Target for Heart Failure Therapy- Role of Protein Lysine Acetylation.
    Lee CF; Tian R
    Circ J; 2015; 79(9):1863-70. PubMed ID: 26248514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.
    Akhmedov AT; Rybin V; Marín-García J
    Heart Fail Rev; 2015 Mar; 20(2):227-49. PubMed ID: 25192828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium Signaling and Reactive Oxygen Species in Mitochondria.
    Bertero E; Maack C
    Circ Res; 2018 May; 122(10):1460-1478. PubMed ID: 29748369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial membrane transporters and metabolic switch in heart failure.
    Kumar V; Santhosh Kumar TR; Kartha CC
    Heart Fail Rev; 2019 Mar; 24(2):255-267. PubMed ID: 30535838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondrial permeability transition pore as a target of cardioprotective signaling.
    Baines CP
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H903-4. PubMed ID: 17513492
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.
    Paradies G; Paradies V; Ruggiero FM; Petrosillo G
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1341-H1352. PubMed ID: 30095969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria in Structural and Functional Cardiac Remodeling.
    Torrealba N; Aranguiz P; Alonso C; Rothermel BA; Lavandero S
    Adv Exp Med Biol; 2017; 982():277-306. PubMed ID: 28551793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial centrality in heart failure.
    Marín-García J; Goldenthal MJ
    Heart Fail Rev; 2008 Jun; 13(2):137-50. PubMed ID: 18185992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oxidative stress sensitizes the mitochondrial permeability transition pore to opening in heart from Zucker Fa/fa rats with type 2 diabetes.
    Riojas-Hernández A; Bernal-Ramírez J; Rodríguez-Mier D; Morales-Marroquín FE; Domínguez-Barragán EM; Borja-Villa C; Rivera-Álvarez I; García-Rivas G; Altamirano J; García N
    Life Sci; 2015 Nov; 141():32-43. PubMed ID: 26407476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac-specific Conditional Knockout of the 18-kDa Mitochondrial Translocator Protein Protects from Pressure Overload Induced Heart Failure.
    Thai PN; Daugherty DJ; Frederich BJ; Lu X; Deng W; Bers DM; Dedkova EN; Schaefer S
    Sci Rep; 2018 Nov; 8(1):16213. PubMed ID: 30385779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection.
    Javadov S; Karmazyn M
    Cell Physiol Biochem; 2007; 20(1-4):1-22. PubMed ID: 17595511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria as Therapeutic Targets in Heart Failure.
    Schwemmlein J; Maack C; Bertero E
    Curr Heart Fail Rep; 2022 Apr; 19(2):27-37. PubMed ID: 35147851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fondation Leducq Transatlantic Network of Excellence Targeting Mitochondria to Treat Heart Disease.
    Murphy E; Bernardi P; Cohen M; Di Lisa F; Forte M; Molkentin JD; Ovize M
    Circ Res; 2019 Apr; 124(9):1294-1296. PubMed ID: 31021720
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondrial Bioenergetics and Dysfunction in Failing Heart.
    Sheeran FL; Pepe S
    Adv Exp Med Biol; 2017; 982():65-80. PubMed ID: 28551782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial network remodeling of the diabetic heart: implications to ischemia related cardiac dysfunction.
    Rudokas MW; McKay M; Toksoy Z; Eisen JN; Bögner M; Young LH; Akar FG
    Cardiovasc Diabetol; 2024 Jul; 23(1):261. PubMed ID: 39026280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.